METOPROLOL TARTRATE INJECTION

METOPROLOL TARTRATE INJECTION was reported 190755 times

METOPROLOL TARTRATE INJECTION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EJECTION FRACTION 217 0.3735
1 BRASH SYNDROME 477 0.3397
2 SENSITISATION 240 0.3162
3 PRODUCT MONITORING ERROR 270 0.1869
4 NEPHROGENIC ANAEMIA 726 0.1566
5 POLYCYSTIC OVARIES 240 0.1546
6 HYPERPARATHYROIDISM SECONDARY 373 0.1487
7 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 147 0.1384
8 EJECTION FRACTION ABNORMAL 145 0.1183
9 REBOUND ACID HYPERSECRETION 301 0.0994
10 SYSTEMIC INFECTION 149 0.0898
11 END STAGE RENAL DISEASE 1607 0.0880
12 HAEMORRHAGIC ANAEMIA 310 0.0705
13 SUSPECTED SUICIDE 319 0.0680
14 RHINITIS ALLERGIC 280 0.0628
15 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 532 0.0601
16 BLOOD PRESSURE DIASTOLIC ABNORMAL 146 0.0573
17 CHRONIC KIDNEY DISEASE 4293 0.0564
18 ATRIAL FLUTTER 430 0.0538
19 ATRIAL FIBRILLATION 5125 0.0526
20 CLOSTRIDIUM TEST POSITIVE 115 0.0521
21 TACHYARRHYTHMIA 124 0.0496
22 CORONARY ARTERY OCCLUSION 676 0.0492
23 HEART VALVE INCOMPETENCE 141 0.0492
24 CORONARY ARTERY STENOSIS 246 0.0489
25 ATRIOVENTRICULAR BLOCK FIRST DEGREE 207 0.0477
26 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 190 0.0465
27 DIASTOLIC DYSFUNCTION 143 0.0463
28 BLOOD PRESSURE SYSTOLIC ABNORMAL 114 0.0461
29 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 113 0.0457
30 ANGINA UNSTABLE 295 0.0453
31 CARDIAC FAILURE CHRONIC 192 0.0450
32 BRADYCARDIA 2370 0.0446
33 LOWER GASTROINTESTINAL HAEMORRHAGE 325 0.0439
34 SINUS BRADYCARDIA 424 0.0438
35 CORONARY ARTERY DISEASE 1325 0.0437
36 AORTIC STENOSIS 151 0.0433
37 ORTHOPNOEA 137 0.0430
38 PATENT DUCTUS ARTERIOSUS 169 0.0425
39 ISCHAEMIC CARDIOMYOPATHY 129 0.0420
40 ATRIOVENTRICULAR BLOCK COMPLETE 274 0.0409
41 ATRIOVENTRICULAR BLOCK 312 0.0403
42 CARDIOGENIC SHOCK 578 0.0402
43 ACUTE MYOCARDIAL INFARCTION 1187 0.0402
44 HAEMORRHOIDAL HAEMORRHAGE 192 0.0393
45 CORONARY ARTERIAL STENT INSERTION 198 0.0390
46 CORONARY ARTERY BYPASS 223 0.0387
47 PROSTATOMEGALY 152 0.0386
48 ACUTE CORONARY SYNDROME 318 0.0384
49 VENTRICULAR HYPOKINESIA 123 0.0383
50 UPPER GASTROINTESTINAL HAEMORRHAGE 638 0.0379
51 AORTIC VALVE INCOMPETENCE 160 0.0376
52 VENTRICULAR TACHYCARDIA 614 0.0371
53 PRODUCT PRESCRIBING ERROR 880 0.0369
54 MITRAL VALVE INCOMPETENCE 415 0.0366
55 COMPLETED SUICIDE 3026 0.0363
56 HEART RATE DECREASED 1272 0.0362
57 RENAL INJURY 1075 0.0362
58 INTERNAL HAEMORRHAGE 412 0.0360
59 BLOOD PRESSURE SYSTOLIC INCREASED 703 0.0360
60 HAIR DISORDER 296 0.0359
61 INTERNATIONAL NORMALISED RATIO DECREASED 145 0.0358
62 TROPONIN INCREASED 271 0.0356
63 BLOOD TEST ABNORMAL 500 0.0356
64 HYPOVOLAEMIA 208 0.0355
65 CARDIAC VALVE DISEASE 203 0.0355
66 MICTURITION DISORDER 123 0.0354
67 BUNDLE BRANCH BLOCK LEFT 149 0.0351
68 SUPRAVENTRICULAR TACHYCARDIA 336 0.0351
69 SUPRAVENTRICULAR EXTRASYSTOLES 118 0.0349
70 ACUTE KIDNEY INJURY 5345 0.0349
71 GOUT 625 0.0348
72 BLOOD PRESSURE DIASTOLIC DECREASED 257 0.0348
73 HYPERTENSIVE CRISIS 387 0.0348
74 LEFT VENTRICULAR FAILURE 119 0.0345
75 VENTRICULAR EXTRASYSTOLES 357 0.0343
76 LEFT VENTRICULAR DYSFUNCTION 228 0.0340
77 SLEEP APNOEA SYNDROME 649 0.0340
78 CARDIAC FAILURE CONGESTIVE 2728 0.0339
79 ARTERIOSCLEROSIS CORONARY ARTERY 225 0.0339
80 ANGINA PECTORIS 958 0.0334
81 INTERNATIONAL NORMALISED RATIO ABNORMAL 114 0.0331
82 TRICUSPID VALVE INCOMPETENCE 262 0.0329
83 BODY TEMPERATURE DECREASED 324 0.0329
84 DIVERTICULUM 233 0.0328
85 CARPAL TUNNEL SYNDROME 458 0.0327
86 PSYCHOLOGICAL TRAUMA 282 0.0326
87 ARTERIOSCLEROSIS 307 0.0326
88 EXERCISE TOLERANCE DECREASED 187 0.0325
89 LEFT VENTRICULAR HYPERTROPHY 138 0.0322
90 ATRIAL SEPTAL DEFECT 270 0.0322
91 SKIN ABRASION 152 0.0321
92 SMALL FOR DATES BABY 159 0.0320
93 BLOOD MAGNESIUM DECREASED 276 0.0319
94 NEPHROPATHY 296 0.0317
95 RENAL CYST 251 0.0316
96 DYSPNOEA EXERTIONAL 1188 0.0315
97 BLOOD PRESSURE FLUCTUATION 757 0.0315
98 HEART RATE IRREGULAR 712 0.0315
99 HAIR COLOUR CHANGES 392 0.0315
100 HIATUS HERNIA 406 0.0313
101 EJECTION FRACTION DECREASED 487 0.0313
102 HEART RATE ABNORMAL 174 0.0312
103 BLOOD CREATINE INCREASED 136 0.0307
104 RENAL FAILURE 4044 0.0304
105 GLOMERULAR FILTRATION RATE DECREASED 374 0.0304
106 GASTROINTESTINAL HAEMORRHAGE 2542 0.0304
107 BODY HEIGHT DECREASED 325 0.0304
108 PULSELESS ELECTRICAL ACTIVITY 127 0.0304
109 BLOOD URINE PRESENT 575 0.0303
110 HYPERKALAEMIA 1056 0.0301
111 DIVERTICULUM INTESTINAL 131 0.0299
112 CARDIAC FAILURE ACUTE 199 0.0298
113 ELECTROLYTE IMBALANCE 345 0.0297
114 ARTERIAL OCCLUSIVE DISEASE 232 0.0295
115 HYPOTENSION 5913 0.0294
116 COAGULOPATHY 489 0.0293
117 BLOOD PRESSURE SYSTOLIC DECREASED 132 0.0290
118 RALES 168 0.0289
119 SPINAL OSTEOARTHRITIS 254 0.0289
120 HYPERVOLAEMIA 142 0.0287
121 PERIPHERAL VASCULAR DISORDER 148 0.0287
122 CARDIAC FLUTTER 185 0.0286
123 CARDIAC PACEMAKER INSERTION 170 0.0285
124 SPINAL COLUMN STENOSIS 134 0.0283
125 HYPERLIPIDAEMIA 337 0.0282
126 HAIR TEXTURE ABNORMAL 374 0.0279
127 DIZZINESS POSTURAL 271 0.0279
128 STENT PLACEMENT 225 0.0279
129 HAEMORRHAGIC STROKE 217 0.0278
130 HAEMATOMA 717 0.0276
131 INTERNATIONAL NORMALISED RATIO INCREASED 788 0.0276
132 HAEMATOCHEZIA 1522 0.0275
133 BLOOD PRESSURE DIASTOLIC INCREASED 127 0.0275
134 TUBULOINTERSTITIAL NEPHRITIS 515 0.0275
135 CATHETERISATION CARDIAC 121 0.0273
136 BLOOD POTASSIUM INCREASED 443 0.0273
137 GLUCOSE TOLERANCE IMPAIRED 161 0.0272
138 WEIGHT FLUCTUATION 284 0.0271
139 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 139 0.0271
140 HYPOMAGNESAEMIA 377 0.0271
141 ELECTROCARDIOGRAM ABNORMAL 212 0.0270
142 HAEMATURIA 915 0.0267
143 GENERAL PHYSICAL HEALTH DETERIORATION 3063 0.0264
144 BUNDLE BRANCH BLOCK RIGHT 121 0.0263
145 ACUTE RESPIRATORY FAILURE 506 0.0263
146 VENTRICULAR FIBRILLATION 292 0.0263
147 ARRHYTHMIA 1244 0.0262
148 FLANK PAIN 246 0.0262
149 UROSEPSIS 242 0.0262
150 ORTHOSTATIC HYPOTENSION 456 0.0262
151 ANEURYSM 130 0.0261
152 AORTIC ANEURYSM 198 0.0260
153 CARDIOMEGALY 320 0.0260
154 POLYP 170 0.0259
155 INCREASED TENDENCY TO BRUISE 237 0.0257
156 INTERVERTEBRAL DISC DEGENERATION 238 0.0257
157 SYNCOPE 2567 0.0256
158 ABDOMINAL HERNIA 117 0.0256
159 RENAL FUNCTION TEST ABNORMAL 119 0.0256
160 PRESYNCOPE 620 0.0255
161 MYOPATHY 220 0.0254
162 IRON DEFICIENCY ANAEMIA 234 0.0253
163 MYOCARDIAL INFARCTION 4400 0.0252
164 CIRCULATORY COLLAPSE 429 0.0252
165 MADAROSIS 292 0.0251
166 PULSE ABSENT 119 0.0250
167 TORSADE DE POINTES 196 0.0250
168 BLOOD PRESSURE INADEQUATELY CONTROLLED 150 0.0249
169 HYPOKALAEMIA 1146 0.0248
170 EXTRASYSTOLES 173 0.0248
171 RENAL TUBULAR NECROSIS 242 0.0246
172 BLOOD IRON DECREASED 292 0.0246
173 BENIGN PROSTATIC HYPERPLASIA 127 0.0246
174 BLOOD PRESSURE INCREASED 3755 0.0245
175 MENISCUS INJURY 151 0.0245
176 OSTEOARTHRITIS 1040 0.0245
177 PULMONARY OEDEMA 1098 0.0245
178 DRUG INTERACTION 3884 0.0245
179 HYPOVOLAEMIC SHOCK 117 0.0244
180 BLOOD UREA INCREASED 406 0.0242
181 GASTRITIS EROSIVE 113 0.0242
182 DYSLIPIDAEMIA 123 0.0242
183 ECCHYMOSIS 166 0.0242
184 RECTAL HAEMORRHAGE 1034 0.0240
185 ATELECTASIS 232 0.0240
186 IMPAIRED GASTRIC EMPTYING 327 0.0240
187 DRUG LEVEL INCREASED 397 0.0240
188 URINE ODOUR ABNORMAL 141 0.0240
189 RHABDOMYOLYSIS 1000 0.0240
190 MELAENA 527 0.0239
191 CLOSTRIDIUM DIFFICILE COLITIS 253 0.0238
192 POLYURIA 195 0.0238
193 HEART RATE INCREASED 2358 0.0238
194 SUBDURAL HAEMATOMA 340 0.0237
195 CARDIAC FAILURE 1896 0.0236
196 BLOOD CREATININE INCREASED 1541 0.0236
197 ENDOCARDITIS 121 0.0236
198 CARDIOMYOPATHY 348 0.0235
199 BLOOD POTASSIUM DECREASED 705 0.0234
200 LACERATION 220 0.0234
201 DEHYDRATION 3114 0.0233
202 SUBARACHNOID HAEMORRHAGE 237 0.0232
203 TRANSIENT ISCHAEMIC ATTACK 785 0.0232
204 LARGE INTESTINE POLYP 161 0.0232
205 DIABETIC NEUROPATHY 115 0.0232
206 ABNORMAL LOSS OF WEIGHT 157 0.0230
207 MYOCARDIAL ISCHAEMIA 262 0.0230
208 POST PROCEDURAL HAEMORRHAGE 268 0.0230
209 URINE OUTPUT DECREASED 201 0.0230
210 CARDIAC DISORDER 2148 0.0229
211 BLOOD PRESSURE DECREASED 1524 0.0229
212 GASTRIC ULCER HAEMORRHAGE 127 0.0229
213 MENTAL STATUS CHANGES 635 0.0228
214 BLOOD URIC ACID INCREASED 132 0.0228
215 TRANSFUSION 239 0.0228
216 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 386 0.0227
217 PULMONARY HYPERTENSION 472 0.0226
218 PLEURAL EFFUSION 1376 0.0226
219 EPISTAXIS 1687 0.0225
220 FOETAL GROWTH RESTRICTION 137 0.0225
221 BLOOD SODIUM DECREASED 424 0.0225
222 HAEMODYNAMIC INSTABILITY 171 0.0224
223 PULMONARY MASS 332 0.0223
224 HYPERTHYROIDISM 320 0.0221
225 METABOLIC ACIDOSIS 704 0.0220
226 FAECES DISCOLOURED 477 0.0220
227 PULMONARY CONGESTION 289 0.0219
228 RENAL IMPAIRMENT 1832 0.0218
229 HAEMOGLOBIN DECREASED 2236 0.0218
230 OEDEMA PERIPHERAL 2651 0.0217
231 ULCER HAEMORRHAGE 147 0.0217
232 HYPERTENSION 4592 0.0217
233 HAEMATOCRIT DECREASED 429 0.0216
234 DRUG PRESCRIBING ERROR 415 0.0216
235 ACIDOSIS 165 0.0216
236 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1121 0.0215
237 SINUS TACHYCARDIA 305 0.0215
238 LOCALISED INFECTION 519 0.0214
239 LACTIC ACIDOSIS 694 0.0214
240 NOCTURIA 260 0.0214
241 HYPOTHYROIDISM 682 0.0213
242 FALL 7107 0.0213
243 BASAL CELL CARCINOMA 333 0.0213
244 NERVE COMPRESSION 197 0.0213
245 STRESS CARDIOMYOPATHY 124 0.0213
246 FLUID RETENTION 1081 0.0212
247 ORAL PAIN 474 0.0211
248 DECREASED ACTIVITY 228 0.0211
249 SHOCK HAEMORRHAGIC 172 0.0211
250 GASTROOESOPHAGEAL REFLUX DISEASE 1697 0.0211
251 SKIN LACERATION 228 0.0209
252 ANAEMIA 3998 0.0209
253 CARDIAC ARREST 1729 0.0209
254 PROSTATIC SPECIFIC ANTIGEN INCREASED 288 0.0209
255 BLOOD PRESSURE ABNORMAL 415 0.0209
256 HYPERKERATOSIS 115 0.0208
257 RIB FRACTURE 426 0.0207
258 UNRESPONSIVE TO STIMULI 533 0.0206
259 PERIPHERAL SWELLING 3176 0.0206
260 GROIN PAIN 181 0.0206
261 FIBROMYALGIA 501 0.0206
262 CONTUSION 1982 0.0206
263 PALLOR 560 0.0206
264 LYMPHOEDEMA 142 0.0205
265 DIVERTICULITIS 569 0.0205
266 RENAL DISORDER 956 0.0205
267 MUSCULOSKELETAL PAIN 1074 0.0205
268 CHEST PAIN 3786 0.0204
269 HAEMOPTYSIS 570 0.0204
270 PELVIC FRACTURE 158 0.0203
271 LUNG INFILTRATION 179 0.0202
272 CEREBRAL HAEMORRHAGE 725 0.0202
273 CHROMATURIA 457 0.0202
274 PERICARDIAL EFFUSION 468 0.0202
275 FULL BLOOD COUNT ABNORMAL 214 0.0202
276 HAEMORRHAGE INTRACRANIAL 302 0.0202
277 HOSPICE CARE 199 0.0201
278 HYPONATRAEMIA 1127 0.0200
279 DYSURIA 733 0.0199
280 RENAL FAILURE CHRONIC 153 0.0199
281 FLUID OVERLOAD 287 0.0197
282 PLATELET COUNT INCREASED 257 0.0197
283 DUODENAL ULCER 139 0.0197
284 FAECES SOFT 143 0.0196
285 HYPOTHERMIA 199 0.0196
286 MACULAR DEGENERATION 234 0.0196
287 BLOOD COUNT ABNORMAL 297 0.0196
288 ROTATOR CUFF SYNDROME 251 0.0195
289 POLLAKIURIA 813 0.0195
290 DYSPNOEA 11031 0.0195
291 INGUINAL HERNIA 118 0.0194
292 SPLENOMEGALY 226 0.0193
293 BLOOD ALBUMIN DECREASED 153 0.0193
294 HYPOGLYCAEMIA 932 0.0192
295 RED BLOOD CELL COUNT DECREASED 549 0.0192
296 SMALL INTESTINAL OBSTRUCTION 236 0.0192
297 HYPOXIA 675 0.0191
298 WALKING AID USER 126 0.0191
299 SKIN ULCER 493 0.0191
300 CHOLELITHIASIS 625 0.0190
301 GASTRIC ULCER 362 0.0190
302 PERIPHERAL COLDNESS 261 0.0190
303 CARDIAC OPERATION 163 0.0189
304 POSTOPERATIVE WOUND INFECTION 128 0.0189
305 HEAD INJURY 598 0.0189
306 ISCHAEMIC STROKE 337 0.0189
307 VITAMIN D DECREASED 161 0.0188
308 EYE HAEMORRHAGE 251 0.0188
309 MUSCULOSKELETAL CHEST PAIN 291 0.0188
310 URINARY TRACT INFECTION 3196 0.0187
311 ASTHENIA 7034 0.0187
312 DEMENTIA 522 0.0187
313 HAEMORRHOIDS 364 0.0186
314 MUSCLE STRAIN 161 0.0186
315 TOOTH ABSCESS 189 0.0185
316 CLOSTRIDIUM DIFFICILE INFECTION 405 0.0185
317 BOWEL MOVEMENT IRREGULARITY 142 0.0185
318 HYPERCHOLESTEROLAEMIA 179 0.0185
319 CYSTITIS 589 0.0185
320 PETECHIAE 193 0.0185
321 DIZZINESS 9212 0.0185
322 HYPOPHAGIA 472 0.0184
323 SCIATICA 294 0.0184
324 HIP FRACTURE 593 0.0184
325 TOXICITY TO VARIOUS AGENTS 3102 0.0184
326 CATARACT 1094 0.0184
327 OLIGURIA 114 0.0183
328 WOUND 513 0.0183
329 INTERVERTEBRAL DISC PROTRUSION 401 0.0183
330 LIMB INJURY 497 0.0183
331 TACHYCARDIA 1625 0.0183
332 ANAL INCONTINENCE 164 0.0182
333 INITIAL INSOMNIA 187 0.0182
334 RENAL FAILURE ACUTE 773 0.0182
335 HAEMOGLOBIN ABNORMAL 117 0.0182
336 OXYGEN SATURATION DECREASED 1022 0.0182
337 GASTRITIS 478 0.0181
338 BALANCE DISORDER 1568 0.0181
339 HYPOTONIA 181 0.0181
340 OSTEOPENIA 275 0.0181
341 HEPATIC STEATOSIS 337 0.0181
342 GINGIVAL BLEEDING 246 0.0180
343 ANHEDONIA 473 0.0180
344 BLOOD CALCIUM DECREASED 202 0.0179
345 CONTRAINDICATED PRODUCT ADMINISTERED 543 0.0179
346 WEIGHT DECREASED 5006 0.0179
347 CELLULITIS 903 0.0179
348 URINARY RETENTION 597 0.0179
349 PRODUCTIVE COUGH 852 0.0178
350 FLATULENCE 1008 0.0178
351 FULL BLOOD COUNT DECREASED 358 0.0177
352 LOW BIRTH WEIGHT BABY 141 0.0177
353 EXOSTOSIS 162 0.0177
354 SHOCK 408 0.0177
355 PRODUCT LABEL ISSUE 120 0.0177
356 PALPITATIONS 2062 0.0176
357 DELIRIUM 611 0.0176
358 MUSCULAR WEAKNESS 1998 0.0176
359 TACHYPNOEA 239 0.0176
360 OESOPHAGITIS 192 0.0176
361 DECUBITUS ULCER 143 0.0175
362 HYPOCALCAEMIA 332 0.0175
363 HEMIPARESIS 297 0.0175
364 BLOOD TRIGLYCERIDES INCREASED 309 0.0175
365 RESPIRATORY FAILURE 1275 0.0175
366 WHEEZING 1034 0.0174
367 VITAMIN D DEFICIENCY 170 0.0174
368 TOOTH FRACTURE 192 0.0174
369 ARTHRITIS 1368 0.0174
370 DECREASED APPETITE 4035 0.0174
371 HYPERGLYCAEMIA 633 0.0174
372 HAEMATEMESIS 439 0.0173
373 ECONOMIC PROBLEM 261 0.0172
374 SQUAMOUS CELL CARCINOMA 162 0.0172
375 DYSSTASIA 502 0.0172
376 ASPIRATION 188 0.0171
377 CARDIAC MURMUR 148 0.0171
378 OSTEOPOROSIS 703 0.0171
379 TOOTH INFECTION 225 0.0171
380 MOUTH HAEMORRHAGE 125 0.0170
381 CARDIO-RESPIRATORY ARREST 712 0.0170
382 PARKINSONISM 166 0.0170
383 UPPER-AIRWAY COUGH SYNDROME 140 0.0170
384 RIGHT VENTRICULAR FAILURE 119 0.0170
385 INCONTINENCE 179 0.0169
386 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 812 0.0169
387 SEPSIS 1885 0.0169
388 BLOOD DISORDER 135 0.0168
389 AGEUSIA 420 0.0168
390 SPINAL COMPRESSION FRACTURE 139 0.0168
391 URINARY INCONTINENCE 497 0.0168
392 WHITE BLOOD CELL COUNT INCREASED 643 0.0167
393 TASTE DISORDER 339 0.0167
394 PULMONARY THROMBOSIS 182 0.0167
395 TOOTH DISORDER 370 0.0166
396 POLYNEUROPATHY 199 0.0166
397 MUSCULOSKELETAL DISCOMFORT 286 0.0166
398 COUGH 4655 0.0166
399 LIGAMENT SPRAIN 164 0.0166
400 PRODUCT ADMINISTRATION ERROR 335 0.0166
401 DIABETES MELLITUS INADEQUATE CONTROL 293 0.0165
402 JOINT EFFUSION 114 0.0165
403 PNEUMONIA 5347 0.0165
404 RETCHING 352 0.0165
405 RENAL PAIN 175 0.0165
406 GAIT DISTURBANCE 3158 0.0165
407 ERUCTATION 319 0.0165
408 ELECTROCARDIOGRAM QT PROLONGED 593 0.0165
409 HEPATOMEGALY 162 0.0165
410 COVID-19 PNEUMONIA 194 0.0164
411 DYSPHONIA 960 0.0164
412 BONE DISORDER 299 0.0164
413 ADRENAL INSUFFICIENCY 199 0.0164
414 CHEST DISCOMFORT 1679 0.0164
415 JOINT DISLOCATION 173 0.0163
416 ABNORMAL FAECES 134 0.0163
417 EATING DISORDER 348 0.0163
418 GASTROENTERITIS 238 0.0163
419 SCAB 186 0.0163
420 LOW DENSITY LIPOPROTEIN INCREASED 126 0.0163
421 DYSPEPSIA 1598 0.0162
422 GENERALISED OEDEMA 201 0.0162
423 OBESITY 258 0.0162
424 PRESCRIBED UNDERDOSE 323 0.0162
425 DIARRHOEA 10419 0.0161
426 FACIAL PAIN 144 0.0161
427 RESPIRATORY RATE INCREASED 143 0.0161
428 BRONCHITIS 1190 0.0161
429 CONSTIPATION 3506 0.0161
430 TOOTHACHE 291 0.0161
431 POOR QUALITY SLEEP 346 0.0161
432 LIMB DISCOMFORT 496 0.0160
433 CEREBROVASCULAR ACCIDENT 2713 0.0160
434 HALLUCINATION, VISUAL 338 0.0160
435 ENCEPHALOPATHY 393 0.0160
436 SLUGGISHNESS 163 0.0160
437 HYPERSOMNIA 458 0.0160
438 NEURALGIA 388 0.0159
439 WRIST FRACTURE 191 0.0159
440 SKIN HAEMORRHAGE 236 0.0159
441 DENTAL CARIES 176 0.0159
442 UPPER LIMB FRACTURE 316 0.0158
443 NEPHROLITHIASIS 727 0.0158
444 HYPOKINESIA 230 0.0158
445 PREMATURE DELIVERY 252 0.0158
446 MALNUTRITION 177 0.0158
447 OEDEMA 858 0.0158
448 MUSCLE ATROPHY 200 0.0158
449 ABDOMINAL PAIN LOWER 398 0.0157
450 TENDERNESS 164 0.0157
451 LEUKOCYTOSIS 284 0.0157
452 FRACTURE 297 0.0157
453 EAR DISCOMFORT 161 0.0157
454 BACK DISORDER 255 0.0157
455 CONFUSIONAL STATE 2533 0.0157
456 BURSITIS 190 0.0156
457 GINGIVAL PAIN 124 0.0156
458 FATIGUE 12112 0.0155
459 GASTROINTESTINAL PAIN 171 0.0155
460 BACK INJURY 169 0.0155
461 SPINAL PAIN 182 0.0155
462 CHOLECYSTITIS 185 0.0155
463 BURNING SENSATION 1088 0.0155
464 THROMBOSIS 1246 0.0155
465 ANURIA 133 0.0154
466 HALLUCINATION 1164 0.0154
467 PAIN IN EXTREMITY 4526 0.0153
468 MICTURITION URGENCY 175 0.0153
469 DRY MOUTH 1243 0.0153
470 BACK PAIN 3548 0.0153
471 APHASIA 461 0.0153
472 VITREOUS FLOATERS 150 0.0152
473 HERNIA 295 0.0152
474 SKIN DISCOLOURATION 701 0.0152
475 LOCAL SWELLING 266 0.0152
476 EMPHYSEMA 153 0.0152
477 HICCUPS 124 0.0151
478 FLUSHING 1532 0.0151
479 GASTROINTESTINAL INFECTION 135 0.0150
480 RHINORRHOEA 973 0.0150
481 DYSGEUSIA 1118 0.0150
482 PLATELET COUNT DECREASED 1602 0.0150
483 DYSARTHRIA 565 0.0150
484 CONCUSSION 116 0.0150
485 HYPOACUSIS 642 0.0149
486 SECOND PRIMARY MALIGNANCY 124 0.0149
487 STAPHYLOCOCCAL INFECTION 491 0.0149
488 FOOT FRACTURE 282 0.0149
489 COLD SWEAT 262 0.0149
490 HEAD DISCOMFORT 263 0.0148
491 MASS 207 0.0148
492 SPUTUM DISCOLOURED 140 0.0147
493 ABDOMINAL PAIN UPPER 3039 0.0147
494 LOSS OF CONSCIOUSNESS 1881 0.0147
495 NIGHT SWEATS 473 0.0147
496 SPINAL DISORDER 139 0.0147
497 GAIT INABILITY 490 0.0146
498 TYPE 2 DIABETES MELLITUS 493 0.0146
499 DEPRESSED LEVEL OF CONSCIOUSNESS 579 0.0146
500 POST PROCEDURAL COMPLICATION 281 0.0146
501 FEELING COLD 407 0.0146
502 SINUS DISORDER 289 0.0146
503 BLOOD THYROID STIMULATING HORMONE INCREASED 134 0.0145
504 JOINT INJURY 311 0.0145
505 DISORIENTATION 576 0.0145
506 NECK PAIN 812 0.0145
507 IMPAIRED HEALING 477 0.0145
508 ABDOMINAL PAIN 3377 0.0145
509 CANDIDA INFECTION 245 0.0145
510 PNEUMONITIS 395 0.0145
511 HYPERHIDROSIS 1868 0.0145
512 EAR PAIN 281 0.0144
513 LETHARGY 830 0.0144
514 VASCULITIS 168 0.0144
515 BLADDER DISORDER 143 0.0144
516 BLOOD CHOLESTEROL INCREASED 671 0.0144
517 SINUS CONGESTION 194 0.0143
518 SKIN CANCER 309 0.0143
519 WOUND INFECTION 157 0.0143
520 NODULE 187 0.0143
521 THYROID DISORDER 220 0.0143
522 SEROTONIN SYNDROME 274 0.0143
523 FURUNCLE 113 0.0142
524 FOOT DEFORMITY 158 0.0142
525 BLINDNESS UNILATERAL 201 0.0142
526 PURPURA 126 0.0142
527 MEDICATION ERROR 789 0.0142
528 MULTIPLE ORGAN DYSFUNCTION SYNDROME 402 0.0142
529 GLYCOSYLATED HAEMOGLOBIN INCREASED 357 0.0141
530 FEELING HOT 864 0.0141
531 OSTEOMYELITIS 255 0.0141
532 RESTLESS LEGS SYNDROME 256 0.0141
533 BACTERAEMIA 167 0.0141
534 SCRATCH 148 0.0140
535 BLOOD CALCIUM INCREASED 123 0.0140
536 BODY TEMPERATURE INCREASED 286 0.0140
537 LIVER FUNCTION TEST ABNORMAL 407 0.0140
538 DYSPHAGIA 1328 0.0140
539 IMPAIRED QUALITY OF LIFE 201 0.0140
540 PNEUMONIA ASPIRATION 349 0.0140
541 ABDOMINAL DISTENSION 1458 0.0140
542 GASTROENTERITIS VIRAL 252 0.0139
543 HAEMORRHAGE 1459 0.0139
544 DELUSION 216 0.0139
545 CHOKING 271 0.0139
546 DEEP VEIN THROMBOSIS 897 0.0138
547 DRY THROAT 140 0.0138
548 ABDOMINAL DISCOMFORT 2305 0.0137
549 DIPLOPIA 356 0.0137
550 NERVE INJURY 152 0.0137
551 INFLUENZA 1521 0.0136
552 CEREBRAL INFARCTION 333 0.0136
553 THIRST 243 0.0136
554 HERPES ZOSTER 781 0.0136
555 RESPIRATORY DISTRESS 375 0.0136
556 PANCYTOPENIA 758 0.0135
557 BLOOD CREATINE PHOSPHOKINASE INCREASED 390 0.0135
558 DIABETES MELLITUS 1031 0.0135
559 PAIN IN JAW 383 0.0135
560 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 129 0.0135
561 QUALITY OF LIFE DECREASED 181 0.0135
562 PULMONARY ARTERIAL HYPERTENSION 195 0.0134
563 CYST 167 0.0134
564 JOINT SWELLING 1623 0.0134
565 MEMORY IMPAIRMENT 1846 0.0134
566 RESPIRATORY ARREST 370 0.0134
567 JOINT RANGE OF MOTION DECREASED 180 0.0134
568 SKIN LESION 368 0.0134
569 ABSCESS 214 0.0134
570 MUSCLE SPASMS 2459 0.0134
571 BRAIN OEDEMA 169 0.0134
572 PRODUCT ODOUR ABNORMAL 140 0.0134
573 FREQUENT BOWEL MOVEMENTS 361 0.0134
574 WEIGHT INCREASED 2990 0.0133
575 INTENTIONAL PRODUCT USE ISSUE 1169 0.0133
576 MUSCLE TIGHTNESS 216 0.0133
577 BLOOD ALKALINE PHOSPHATASE INCREASED 331 0.0133
578 BREAST PAIN 142 0.0133
579 OROPHARYNGEAL PAIN 1232 0.0133
580 MYALGIA 2261 0.0133
581 INCREASED APPETITE 254 0.0133
582 ULCER 211 0.0132
583 APHONIA 185 0.0132
584 MOBILITY DECREASED 952 0.0132
585 UPPER RESPIRATORY TRACT INFECTION 610 0.0132
586 NEUROPATHY PERIPHERAL 1255 0.0132
587 MYOSITIS 118 0.0131
588 CHILLS 1538 0.0131
589 GLAUCOMA 252 0.0131
590 SEASONAL ALLERGY 185 0.0131
591 NASAL CONGESTION 768 0.0131
592 MIDDLE INSOMNIA 244 0.0131
593 ATAXIA 155 0.0130
594 NAUSEA 10323 0.0130
595 PREMATURE BABY 392 0.0130
596 KIDNEY INFECTION 255 0.0130
597 ASCITES 382 0.0130
598 NEUTROPHIL COUNT INCREASED 133 0.0130
599 ANKLE FRACTURE 201 0.0130
600 RESPIRATORY TRACT CONGESTION 205 0.0129
601 ORAL DISCOMFORT 179 0.0129
602 INSOMNIA 3430 0.0129
603 ANGIOEDEMA 569 0.0128
604 ARTHRALGIA 5342 0.0128
605 VERTIGO 782 0.0128
606 HYPERCALCAEMIA 158 0.0128
607 INABILITY TO AFFORD MEDICATION 127 0.0128
608 HOT FLUSH 963 0.0128
609 ERECTILE DYSFUNCTION 328 0.0128
610 FEEDING DISORDER 259 0.0128
611 LIVER FUNCTION TEST INCREASED 274 0.0127
612 POOR VENOUS ACCESS 132 0.0127
613 EYE INFECTION 144 0.0127
614 STOMATITIS 773 0.0127
615 SEPTIC SHOCK 553 0.0127
616 COGNITIVE DISORDER 593 0.0127
617 BLOOD GLUCOSE DECREASED 609 0.0127
618 MYOCARDITIS 145 0.0126
619 TREMOR 2096 0.0126
620 SPINAL FRACTURE 253 0.0126
621 RESTLESSNESS 462 0.0126
622 ACUTE HEPATIC FAILURE 172 0.0126
623 ALOPECIA 2471 0.0126
624 INTENTIONAL OVERDOSE 807 0.0126
625 RESPIRATORY DEPRESSION 154 0.0126
626 DRUG-INDUCED LIVER INJURY 394 0.0125
627 PRODUCT TASTE ABNORMAL 170 0.0125
628 SWOLLEN TONGUE 392 0.0125
629 PARAESTHESIA ORAL 181 0.0125
630 VISION BLURRED 1719 0.0125
631 THERAPY CHANGE 123 0.0125
632 BLOOD GLUCOSE FLUCTUATION 137 0.0125
633 BLOOD GLUCOSE ABNORMAL 230 0.0124
634 COVID-19 2176 0.0124
635 BONE PAIN 725 0.0124
636 PRODUCT DOSE OMISSION 804 0.0123
637 PROTEINURIA 234 0.0123
638 DIARRHOEA HAEMORRHAGIC 114 0.0122
639 DIALYSIS 173 0.0122
640 TRANSAMINASES INCREASED 271 0.0122
641 MUSCULOSKELETAL STIFFNESS 1067 0.0122
642 RESPIRATORY TRACT INFECTION 317 0.0122
643 PNEUMOTHORAX 193 0.0122
644 SWELLING 1139 0.0122
645 MOTOR DYSFUNCTION 124 0.0122
646 TINNITUS 559 0.0122
647 INTESTINAL OBSTRUCTION 458 0.0121
648 PANCREATITIS 642 0.0121
649 SOMNOLENCE 2441 0.0121
650 SCAR 207 0.0121
651 SNEEZING 271 0.0121
652 GASTRIC HAEMORRHAGE 139 0.0121
653 ILEUS 150 0.0121
654 DISEASE RECURRENCE 574 0.0121
655 TREATMENT NONCOMPLIANCE 660 0.0121
656 VISUAL IMPAIRMENT 1490 0.0120
657 MALIGNANT MELANOMA 161 0.0120
658 GALLBLADDER DISORDER 214 0.0120
659 PULMONARY EMBOLISM 1139 0.0120
660 LACRIMATION INCREASED 362 0.0120
661 GASTRIC DISORDER 411 0.0120
662 LUNG INFECTION 186 0.0120
663 SPEECH DISORDER 626 0.0119
664 HYPOAESTHESIA 1786 0.0119
665 VOMITING 5603 0.0119
666 NASOPHARYNGITIS 2195 0.0119
667 METASTASES TO BONE 195 0.0119
668 MUSCLE RIGIDITY 142 0.0119
669 FEELING ABNORMAL 2844 0.0119
670 MULTI-ORGAN FAILURE 205 0.0118
671 MYOCLONUS 141 0.0118
672 BLOOD GLUCOSE INCREASED 2226 0.0118
673 SKIN DISORDER 394 0.0118
674 COLITIS 447 0.0118
675 JOINT STIFFNESS 309 0.0118
676 NERVOUSNESS 611 0.0117
677 ANXIETY 3326 0.0117
678 PARAESTHESIA 1838 0.0117
679 AMNESIA 759 0.0117
680 RASH PRURITIC 632 0.0116
681 PRURITUS GENERALISED 252 0.0116
682 FEELING JITTERY 222 0.0116
683 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 639 0.0116
684 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 828 0.0116
685 SINUSITIS 1192 0.0116
686 FEAR 312 0.0116
687 SKIN INFECTION 130 0.0116
688 ARTHROPATHY 644 0.0116
689 GAMMA-GLUTAMYLTRANSFERASE INCREASED 256 0.0115
690 LUNG DISORDER 566 0.0115
691 BLISTER 648 0.0115
692 FUNGAL INFECTION 383 0.0115
693 INFLAMMATION 592 0.0115
694 ORAL CANDIDIASIS 151 0.0115
695 CONDITION AGGRAVATED 3484 0.0114
696 BLOOD BILIRUBIN INCREASED 309 0.0114
697 LIP SWELLING 380 0.0114
698 SALIVARY HYPERSECRETION 114 0.0114
699 LEUKOPENIA 569 0.0114
700 BACTERIAL INFECTION 212 0.0114
701 HYPOAESTHESIA ORAL 171 0.0113
702 PHOTOSENSITIVITY REACTION 187 0.0113
703 METASTASES TO LIVER 199 0.0113
704 LABORATORY TEST ABNORMAL 334 0.0113
705 PULMONARY FIBROSIS 217 0.0113
706 POISONING 142 0.0113
707 DRUG LEVEL DECREASED 115 0.0113
708 THROMBOCYTOPENIA 1261 0.0113
709 MYELODYSPLASTIC SYNDROME 163 0.0113
710 ALANINE AMINOTRANSFERASE INCREASED 691 0.0112
711 PRODUCT PHYSICAL ISSUE 227 0.0112
712 HEPATIC ENZYME INCREASED 766 0.0112
713 PAIN 6897 0.0112
714 MALAISE 4900 0.0112
715 INCORRECT PRODUCT ADMINISTRATION DURATION 242 0.0112
716 FOETAL EXPOSURE DURING PREGNANCY 908 0.0112
717 CARDIOVASCULAR DISORDER 283 0.0111
718 ACUTE RESPIRATORY DISTRESS SYNDROME 197 0.0111
719 NEOPLASM 128 0.0111
720 DEPRESSION 2531 0.0111
721 BEDRIDDEN 146 0.0111
722 THROAT IRRITATION 496 0.0110
723 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 786 0.0110
724 TENDONITIS 171 0.0110
725 SLEEP DISORDER 778 0.0110
726 SECRETION DISCHARGE 138 0.0110
727 TOOTH EXTRACTION 137 0.0110
728 IMMUNE SYSTEM DISORDER 145 0.0110
729 IMPAIRED DRIVING ABILITY 125 0.0110
730 PLASMA CELL MYELOMA 429 0.0110
731 DEVICE RELATED INFECTION 169 0.0110
732 HEADACHE 6865 0.0109
733 RASH MACULAR 382 0.0109
734 PROCEDURAL PAIN 303 0.0109
735 RESPIRATORY DISORDER 326 0.0109
736 PHARYNGITIS 135 0.0109
737 ASPARTATE AMINOTRANSFERASE INCREASED 576 0.0108
738 APATHY 158 0.0108
739 ALTERED STATE OF CONSCIOUSNESS 234 0.0108
740 EYE DISORDER 353 0.0107
741 WHITE BLOOD CELL COUNT DECREASED 1161 0.0107
742 EXPIRED PRODUCT ADMINISTERED 356 0.0107
743 NIGHTMARE 370 0.0107
744 INTENTIONAL PRODUCT MISUSE 936 0.0107
745 KNEE ARTHROPLASTY 225 0.0107
746 THERAPY CESSATION 548 0.0107
747 RASH PAPULAR 239 0.0107
748 MUSCULOSKELETAL DISORDER 202 0.0106
749 OBSTRUCTIVE AIRWAYS DISORDER 118 0.0106
750 VIRAL INFECTION 353 0.0106
751 THERAPEUTIC RESPONSE UNEXPECTED 475 0.0106
752 PRURITUS 4029 0.0105
753 CHOLECYSTECTOMY 119 0.0104
754 PHARYNGEAL OEDEMA 160 0.0104
755 METASTASES TO LUNG 120 0.0104
756 CYANOSIS 163 0.0104
757 ABASIA 256 0.0104
758 ABNORMAL DREAMS 286 0.0103
759 JAUNDICE 277 0.0103
760 DISTURBANCE IN ATTENTION 555 0.0103
761 SWELLING FACE 669 0.0103
762 PARALYSIS 147 0.0103
763 PYREXIA 3553 0.0103
764 COLON CANCER 153 0.0103
765 PANIC ATTACK 374 0.0103
766 LYMPHADENOPATHY 363 0.0102
767 BLOOD LACTATE DEHYDROGENASE INCREASED 162 0.0102
768 DISCOMFORT 623 0.0102
769 HIP ARTHROPLASTY 156 0.0102
770 NEPHROPATHY TOXIC 114 0.0101
771 ACTIVITIES OF DAILY LIVING IMPAIRED 201 0.0101
772 TENDON RUPTURE 125 0.0101
773 DIABETIC KETOACIDOSIS 243 0.0101
774 FEBRILE NEUTROPENIA 667 0.0100
775 PHOTOPHOBIA 189 0.0100
776 PRODUCT SUBSTITUTION ISSUE 578 0.0100
777 BRAIN FOG 157 0.0100
778 PANCREATITIS ACUTE 225 0.0100
779 HEPATIC CIRRHOSIS 188 0.0100
780 DEPRESSED MOOD 528 0.0100
781 DYSKINESIA 405 0.0100
782 GLOSSODYNIA 223 0.0100
783 EAR INFECTION 264 0.0099
784 GASTROINTESTINAL DISORDER 886 0.0099
785 MOVEMENT DISORDER 317 0.0099
786 HEPATIC FAILURE 297 0.0098
787 C-REACTIVE PROTEIN INCREASED 358 0.0098
788 LOWER LIMB FRACTURE 189 0.0098
789 INFECTION 1420 0.0098
790 DEAFNESS 256 0.0098
791 SARS-COV-2 TEST POSITIVE 129 0.0098
792 ROAD TRAFFIC ACCIDENT 408 0.0097
793 UNEVALUABLE EVENT 735 0.0097
794 INCORRECT DRUG ADMINISTRATION DURATION 273 0.0097
795 BLINDNESS 394 0.0097
796 SPINAL OPERATION 119 0.0097
797 IMMUNODEFICIENCY 144 0.0097
798 FEMUR FRACTURE 299 0.0096
799 MENTAL IMPAIRMENT 234 0.0096
800 DRUG ADMINISTRATION ERROR 296 0.0096
801 PERICARDITIS 162 0.0096
802 INTRAOCULAR PRESSURE INCREASED 123 0.0096
803 DISEASE PROGRESSION 1137 0.0096
804 SEDATION 251 0.0096
805 DRUG INTOLERANCE 925 0.0096
806 PRODUCT AVAILABILITY ISSUE 218 0.0096
807 HEPATOTOXICITY 213 0.0096
808 DRUG EFFECT INCOMPLETE 347 0.0095
809 GENERALISED TONIC-CLONIC SEIZURE 158 0.0095
810 THERAPY INTERRUPTED 681 0.0095
811 INFUSION RELATED REACTION 631 0.0095
812 SKIN FISSURES 186 0.0095
813 ASTHMA 1074 0.0095
814 THROAT TIGHTNESS 257 0.0095
815 DRUG DOSE OMISSION 1566 0.0095
816 MUSCLE TWITCHING 218 0.0094
817 THINKING ABNORMAL 176 0.0094
818 EYE PAIN 532 0.0094
819 DRY EYE 470 0.0094
820 SENSORY DISTURBANCE 151 0.0094
821 AGITATION 690 0.0094
822 OFF LABEL USE 8198 0.0094
823 VISUAL ACUITY REDUCED 309 0.0093
824 RHEUMATOID ARTHRITIS 1055 0.0093
825 WRONG TECHNIQUE IN DRUG USAGE PROCESS 337 0.0093
826 PRODUCT USE COMPLAINT 146 0.0093
827 PSORIASIS 1209 0.0092
828 RASH 4034 0.0092
829 DEVICE OCCLUSION 129 0.0092
830 SUICIDE ATTEMPT 555 0.0091
831 PRODUCT QUALITY ISSUE 1233 0.0091
832 ACCIDENTAL OVERDOSE 330 0.0090
833 SEIZURE 1041 0.0090
834 PERITONITIS 186 0.0090
835 COMA 426 0.0089
836 PRESCRIBED OVERDOSE 173 0.0089
837 BRONCHOSPASM 127 0.0089
838 PSORIATIC ARTHROPATHY 361 0.0089
839 INSURANCE ISSUE 136 0.0089
840 COORDINATION ABNORMAL 124 0.0089
841 ILLNESS 914 0.0089
842 RASH ERYTHEMATOUS 422 0.0088
843 EYE SWELLING 328 0.0088
844 LIVER DISORDER 390 0.0088
845 ACUTE MYELOID LEUKAEMIA 137 0.0088
846 EYE PRURITUS 295 0.0088
847 INTENTIONAL DOSE OMISSION 250 0.0088
848 PRODUCT USE ISSUE 1643 0.0087
849 MULTIPLE FRACTURES 143 0.0087
850 UNDERDOSE 629 0.0086
851 NEEDLE ISSUE 250 0.0086
852 PRODUCT PRESCRIBING ISSUE 187 0.0086
853 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1534 0.0085
854 ORAL HERPES 166 0.0085
855 ANOSMIA 123 0.0085
856 RASH GENERALISED 220 0.0085
857 TOXIC EPIDERMAL NECROLYSIS 129 0.0085
858 INFLUENZA LIKE ILLNESS 697 0.0085
859 MALIGNANT NEOPLASM PROGRESSION 866 0.0084
860 OSTEONECROSIS OF JAW 209 0.0084
861 THERAPEUTIC PRODUCT EFFECT DECREASED 378 0.0084
862 SKIN EXFOLIATION 711 0.0084
863 PARANOIA 145 0.0084
864 INJECTION SITE MASS 311 0.0084
865 LIVER INJURY 206 0.0084
866 ERYTHEMA 1721 0.0084
867 HOSPITALISATION 1286 0.0084
868 IRRITABLE BOWEL SYNDROME 179 0.0083
869 OCULAR HYPERAEMIA 396 0.0083
870 FACE OEDEMA 140 0.0083
871 LYMPHOCYTE COUNT DECREASED 146 0.0083
872 DERMATITIS 173 0.0082
873 DEATH 7099 0.0082
874 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1668 0.0082
875 PRODUCT DOSE OMISSION IN ERROR 233 0.0082
876 MOUTH ULCERATION 173 0.0082
877 PAIN OF SKIN 220 0.0082
878 DISSEMINATED INTRAVASCULAR COAGULATION 115 0.0082
879 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 190 0.0081
880 CONJUNCTIVITIS 150 0.0081
881 MUCOSAL INFLAMMATION 211 0.0081
882 DRUG EFFECT DECREASED 433 0.0080
883 NEOPLASM PROGRESSION 277 0.0080
884 IMPAIRED WORK ABILITY 170 0.0079
885 HYPERSENSITIVITY 1471 0.0079
886 EXPOSURE DURING PREGNANCY 484 0.0078
887 MENTAL DISORDER 338 0.0078
888 DRUG INEFFECTIVE 10228 0.0078
889 INJURY 544 0.0077
890 DEVICE DELIVERY SYSTEM ISSUE 211 0.0077
891 LUNG NEOPLASM MALIGNANT 316 0.0077
892 ADVERSE EVENT 707 0.0077
893 MIGRAINE 730 0.0076
894 PRODUCT DISPENSING ERROR 166 0.0076
895 PRODUCT USE IN UNAPPROVED INDICATION 1885 0.0076
896 HALLUCINATION, AUDITORY 120 0.0075
897 DRUG DISPENSING ERROR 115 0.0075
898 URTICARIA 1249 0.0074
899 LYMPHOMA 115 0.0074
900 INCORRECT DOSE ADMINISTERED 1691 0.0074
901 EMOTIONAL DISTRESS 893 0.0074
902 NEUROTOXICITY 128 0.0073
903 PSYCHOTIC DISORDER 214 0.0072
904 CHOLESTASIS 139 0.0072
905 PRODUCT DOSE OMISSION ISSUE 2124 0.0072
906 CRYING 262 0.0072
907 THERAPY NON-RESPONDER 323 0.0072
908 NERVOUS SYSTEM DISORDER 224 0.0072
909 DRUG ERUPTION 127 0.0072
910 COLITIS ULCERATIVE 320 0.0072
911 INJECTION SITE BRUISING 569 0.0071
912 WITHDRAWAL SYNDROME 298 0.0071
913 APPLICATION SITE PRURITUS 160 0.0070
914 ILL-DEFINED DISORDER 428 0.0070
915 INJECTION SITE HAEMORRHAGE 561 0.0070
916 LOWER RESPIRATORY TRACT INFECTION 318 0.0070
917 EYE IRRITATION 401 0.0070
918 DRY SKIN 925 0.0069
919 ADVERSE DRUG REACTION 622 0.0069
920 TOOTH LOSS 142 0.0068
921 HEPATITIS 175 0.0068
922 NEUTROPHIL COUNT DECREASED 278 0.0068
923 VAGINAL HAEMORRHAGE 294 0.0068
924 APPLICATION SITE PAIN 149 0.0068
925 APPLICATION SITE ERYTHEMA 177 0.0067
926 OVERDOSE 1455 0.0067
927 SURGERY 391 0.0067
928 NEOPLASM MALIGNANT 445 0.0067
929 EXTRA DOSE ADMINISTERED 270 0.0067
930 STEVENS-JOHNSON SYNDROME 148 0.0067
931 NEUTROPENIA 898 0.0066
932 MOOD ALTERED 177 0.0065
933 DISABILITY 128 0.0065
934 EMOTIONAL DISORDER 199 0.0064
935 AGGRESSION 319 0.0064
936 ANGER 215 0.0064
937 BONE DENSITY DECREASED 199 0.0063
938 THERAPEUTIC RESPONSE SHORTENED 209 0.0063
939 CYTOKINE RELEASE SYNDROME 126 0.0063
940 MATERNAL EXPOSURE DURING PREGNANCY 558 0.0063
941 ABNORMAL BEHAVIOUR 244 0.0062
942 DEVICE MALFUNCTION 430 0.0061
943 THERAPEUTIC RESPONSE DECREASED 371 0.0061
944 INTERSTITIAL LUNG DISEASE 296 0.0061
945 DEVICE ISSUE 544 0.0061
946 INTENTIONAL DRUG MISUSE 126 0.0060
947 INTENTIONAL SELF-INJURY 121 0.0060
948 MOOD SWINGS 184 0.0058
949 ANAPHYLACTIC REACTION 317 0.0057
950 PRODUCT ADHESION ISSUE 205 0.0057
951 EPILEPSY 174 0.0057
952 BONE MARROW FAILURE 115 0.0057
953 IRRITABILITY 340 0.0056
954 INJECTION SITE PAIN 1711 0.0056
955 CONVULSION 319 0.0056
956 SUICIDAL IDEATION 496 0.0054
957 ECZEMA 282 0.0054
958 PANCREATIC CARCINOMA 152 0.0053
959 INJECTION SITE PRURITUS 352 0.0052
960 INJECTION SITE RASH 159 0.0052
961 OSTEONECROSIS 165 0.0050
962 INJECTION SITE URTICARIA 123 0.0050
963 ANAPHYLACTIC SHOCK 128 0.0050
964 INJECTION SITE SWELLING 374 0.0049
965 INJECTION SITE REACTION 334 0.0048
966 INJECTION SITE ERYTHEMA 593 0.0048
967 MULTIPLE SCLEROSIS RELAPSE 319 0.0046
968 SYSTEMIC LUPUS ERYTHEMATOSUS 163 0.0046
969 SKIN BURNING SENSATION 325 0.0045
970 SKIN IRRITATION 207 0.0045
971 MULTIPLE SCLEROSIS 212 0.0044
972 DRUG RESISTANCE 113 0.0044
973 HEPATIC FUNCTION ABNORMAL 164 0.0044
974 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 186 0.0040
975 TREATMENT FAILURE 329 0.0040
976 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 133 0.0039
977 NO ADVERSE EVENT 681 0.0038
978 INCORRECT ROUTE OF DRUG ADMINISTRATION 134 0.0037
979 DRUG DOSE OMISSION BY DEVICE 288 0.0037
980 ACNE 276 0.0036
981 DRUG ABUSE 303 0.0036
982 ACCIDENTAL EXPOSURE TO PRODUCT 374 0.0036
983 DEVICE DISLOCATION 157 0.0036
984 PROSTATE CANCER 283 0.0035
985 DEVICE LEAKAGE 147 0.0034
986 BREAST CANCER 305 0.0033
987 PRODUCT STORAGE ERROR 278 0.0032
988 DRUG WITHDRAWAL SYNDROME 273 0.0031
989 BLADDER CANCER 150 0.0025
990 RENAL CANCER 117 0.0025
991 DEVICE DIFFICULT TO USE 158 0.0024
992 DERMATITIS ATOPIC 121 0.0023
993 DRUG DEPENDENCE 236 0.0015